Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3

Bibliographic Details
Title: Impact of Long-Term Treatment with Belantamab Mafodotin on Safety and Efficacy Outcomes in Patients with Relapsed/Refractory Multiple Myeloma in DREAMM-3
Authors: Hungria, Vania T.M, Weisel, Katja, Radinoff, Atanas, Delimpasi, Sosana, Mikala, Gabor, Masszi, Tamas, Li, Jian, Capra, Marcelo, Maiolino, Angelo, Pappa, Vasiliki, Chraniuk, Dominik, Osipov, Iurii, Leleu, Xavier, Low, Michael, Matsumoto, Morio, Li, Mary, Sule, Neal, Polinkovsky, Margaret, Davis, Randy, Bright, Shelley, McKeown, Astrid, Opalinska, Joanna, Dimopoulos, Meletios Athanasios
Source: In Blood 2 November 2023 142 Supplement 1:3357-3357
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood-2023-178009
Published in:Blood
Language:English